β-Catenin mutations in liver tumors induced by 2-amino-3,4- dimethylimidazo[4,5-f]quinoline in CDF1 mice

Cancer Letters

Volumn 198, Issue 1, 2003, Pages 29-35

  Huang, Hervé ^a   Ushijima, Toshikazu ^b   Nagao, Minako ^b   Sugimura, Takashi ^b   Ohgaki, Hiroko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Liver tumor; MeIQ; Mutation; Catenin

Indexed keywords

2 AMINO 3,4 DIMETHYLIMIDAZO[4,5 F]QUINOLINE; APC PROTEIN; BETA CATENIN; PROTEIN P53; UVOMORULIN; WNT PROTEIN; 2 AMINO 3,4 DIMETHYLIMIDAZO(4,5 F)QUINOLINE; 2-AMINO-3,4-DIMETHYLIMIDAZO(4,5-F)QUINOLINE; CARCINOGEN; CATNB PROTEIN, MOUSE; CYTOSKELETON PROTEIN; QUINOLINE DERIVATIVE; TRANSACTIVATOR PROTEIN;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SCREENING; CARCINOGENESIS; CONTROLLED STUDY; DNA SEQUENCE; EXON; FEMALE; GENE AMPLIFICATION; GENE CLUSTER; GENE MUTATION; GENETIC ANALYSIS; LIVER CELL CARCINOMA; LIVER TUMOR; METHYLATION; MOUSE; MOUSE STRAIN; NONHUMAN; ONCOGENE C MYC; ONCOGENE H RAS; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; ANIMAL; CHEMICALLY INDUCED DISORDER; DNA METHYLATION; GENETICS; MUTATION; ONCOGENE MYC; TUMOR SUPPRESSOR GENE;

ANIMALS; BETA CATENIN; CARCINOGENS; CYTOSKELETAL PROTEINS; DNA METHYLATION; FEMALE; GENE AMPLIFICATION; GENES, APC; GENES, MYC; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MUTATION; QUINOLINES; TRANS-ACTIVATORS;

EID: 0142026845     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00273-8     Document Type: Article

References (43)

1. Buendia M.A. Hepatitis B viruses and hepatocellular carcinoma. Adv. Cancer Res. 59:1992;167-226.
2. Ng I.O., Chung L.P., Tsang S.W., Lam C.L., Lai E.C., Fan S.T., Ng M. p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese. Oncogene. 9:1994;985-990.
3. Caselmann W.H., Alt M. Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma. J. Hepatol. 24:1996;61-66.
4. Idilman R., De Maria N., Colantoni A., Van Thiel D.H. Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma. J. Viral. Hepat. 5:1998;285-299.
5. Montesano R., Hainaut P., Wild C.P. Hepatocellular carcinoma: from gene to public health. J. Natl Cancer Inst. 89:1997;1844-1851.
6. Kanai Y., Ushijima S., Hui A.M., Ochiai A., Tsuda H., Sakamoto M., Hirohashi S. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int. J. Cancer. 71:1997;355-359.
7. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am. J. Pathol. 153:1998;333-339.
8. Slagle B.L., Zhou Y.Z., Birchmeier W., Scorsone K.A. Deletion of the E-cadherin gene in hepatitis B virus-positive Chinese hepatocellular carcinomas. Hepatology. 18:1993;757-762.
9. INK4A gene alterations in hepatocellular carcinoma. Oncogene. 18:1999;789-795.
10. Buendia M.A. Genetics of hepatocellular carcinoma. Semin. Cancer Biol. 10:2000;185-200.
11. Miyoshi Y., Iwao K., Nagasawa Y., Aihara T., Sasaki Y., Imaoka S., Murata M., Shimano T., Nakamura Y. Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res. 58:1998;2524-2527.
12. De La Coste A., Romagnolo B., Billuart P., Renard C.A., Buendia M.A., Soubrane O., Fabre M., Chelly J., Beldjord C., Kahn A., Perret C. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl Acad. Sci. USA. 95:1998;8847-8851.
13. Huang H., Fujii H., Sankila A., Mahler-Araujo B.M., Matsuda M., Cathomas G., Ohgaki H. β-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am. J. Pathol. 156:1999;1795-1801.
14. Peng S.Y., Lai P.L., Hsu H.C. Amplification of the c-myc gene in human hepatocellular carcinoma: biologic significance. J. Formos. Med. Assoc. 92:1993;866-870.
15. Kawate S., Fukusato T., Ohwada S., Watanuki A., Morishita Y. Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression. Oncology. 57:1999;157-163.
16. Tabor E. Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma. J. Med. Virol. 42:1994;357-365.
17. Piao Z., Choi Y., Park C., Lee W.J., Park J.H., Kim H. Deletion of the M6P/IGF2r gene in primary hepatocellular carcinoma. Cancer Lett. 120:1997;39-43.
18. Yamada T., De Souza A.T., Finkelstein S., Jirtle R.L. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc. Natl Acad. Sci. USA. 94:1997;10351-10355.
19. Nishida N., Fukuda Y., Komeda T., Kita R., Sando T., Furukawa M., Amenomori M., Shibagaki I., Nakao K., Ikenaga M. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res. 54:1994;3107-3110.
20. Ozturk M. Genetic aspects of hepatocellular carcinogenesis. Semin. Liver Dis. 19:1999;235-242.
21. Satoh S., Daigo Y., Furukawa Y., Kato T., Miwa N., Nishiwaki T., Kawasoe T., Ishiguro H., Fujita M., Tokino T., Sasaki Y., Imaoka S., Murata M., Shimano T., Yamaoka Y., Nakamura Y. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat. Genet. 24:2000;245-250.
22. Taniguchi K., Roberts L.R., Aderca I.N., Dong X., Qian C., Murphy L.M., Nagorney D.M., Burgart L.J., Roche P.C., Smith D.I., Ross J.A., Liu W. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene. 21:2002;4863-4871.
23. Nagao M., Honda M., Seino Y., Yahagi T., Sugimura T. Mutagenicities of smoke condensates and the charred surface of fish and meat. Cancer Lett. 2:1977;221-226.
24. Sugimura T., Nagao M., Kawachi T., Honda M., Yahagi T., Seino Y., Sato S., Matsukura N. Mutagen-carcinogens in foods, with special reference to highly mutagenic pyrolytic products in broiled foods. Hiatt H.H., Watson J.D., Winstein J.A. Origins of Human Cancer. 1977;1561-1577 Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
25. Ohgaki H. Rodents. Nagao M., Sugimura T. Food Borne Carcinogens: Carcinogenicity in Animals and Specific Organs. 2000;198-228 Wiley, New York.
26. King R.S., Kadlubar F.F., Turesky R.J. In Vivo Metabolism. Nagao M., Sugimura T. Food Borne Carcinogens: Heterocyclic Amines. 2000;90-111 Wiley, New York.
27. Herzog C.R., Schut H.A., Maronpot R.R., You M. ras mutations in 2-amino-3-methylimidazo-[4,5-f]quinoline-induced tumors in the CDF1 mouse. Mol. Carcinog. 8:1993;202-207.
28. Ushijima T., Makino H., Kakiuchi H., Inoue R., Sugimura T., Nagao M. Genetic alterations in HCA-induced tumors. Princess Takamatsu Symp. 23:1995;281-291.
29. Ohgaki H., Hasegawa H., Suenaga M., Kato T., Sato S., Takayama S., Sugimura T. Induction of hepatocellular carcinoma and highly metastatic squamous cell carcinomas in the forestomach of mice by feeding 2-amino-3,4-dimethylimidazo[4,5-f]quinoline. Carcinogenesis. 7:1986;1889-1893.
30. Devereux T.R., Anna C.H., Foley J.F., White C.M., Sills R.C., Barrett J.C. Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis. Oncogene. 18:1999;4726-4733.
31. Miyoshi Y., Ando H., Nagase H., Nishisho I., Horii A., Miki Y., Mori T., Utsunomiya J., Baba S., Petersen G., Hamilton S.R., Kinzler K.W., Vogelstein B., Nakamura Y. Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc. Natl Acad. Sci. USA. 89:1992;4452-4456.
32. Miyoshi Y., Nagase H., Ando H., Horii A., Ichii S., Nakatsuru S., Aoki T., Miki Y., Mori T., Nakamura Y. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum. Mol. Genet. 1:1992;229-233.
33. Yashima K., Nakamori S., Murakami Y., Yamaguchi A., Hayashi K., Ishikawa O., Konishi Y., Sekiya T. Mutations of the adenomatous polyposis coli gene in the mutation cluster region: comparison of human pancreatic and colorectal cancers. Int. J. Cancer. 59:1994;43-47.
34. Ohgaki H., Sanderson N.D., Ton P., Thorgeirsson S.S. Molecular analyses of liver tumors in c-myc transgenic mice and c-myc and TGF-α double transgenic mice. Cancer Lett. 106:1996;43-49.
35. Murakami H., Sanderson N.D., Nagy P., Marino P.A., Merlino G., Thorgeirsson S.S. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Cancer Res. 53:1993;1719-1723.
36. Polakis P. The oncogenic activation of β-catenin. Curr. Opin. Genet. Dev. 9:1999;15-21.
37. Calvisi D.F., Factor V.M., Loi R., Thorgeirsson S.S. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade. Cancer Res. 61:2001;2085-2091.
38. Umeda T., Yamamoto T., Kajino K., Hino O. Beta-catenin mutations are absent in hepatocellular carcinomas of SV40 T-antigen transgenic mice. Int. J. Oncol. 16:2000;1133-1136.
39. Ogawa K., Yamada Y., Kishibe K., Ishizaki K., Tokusashi Y. Beta-catenin mutations are frequent in hepatocellular carcinomas but absent in adenomas induced by diethylnitrosamine in B6C3F1 mice. Cancer Res. 59:1999;1830-1833.
40. Fujimori M., Tokino T., Hino O., Kitagawa T., Imamura T., Okamoto E., Mitsunobu M., Ishikawa T., Nakagama H., Harada H. Allelotype study of primary hepatocellular carcinoma. Cancer Res. 51:1991;89-93.
41. Manenti G., De Gregorio L., Gariboldi M., Dragani T.A., Pierotti M.A. Analysis of loss of heterozygosity in murine hepatocellular tumors. Mol. Carcinog. 13:1995;191-200.
42. Chen T.C., Hsieh L.L., Ng K.F., Jeng L.B., Chen M.F. Absence of APC gene mutation in the mutation cluster region in hepatocellular carcinoma. Cancer Lett. 134:1998;23-28.
43. Horii A., Nakatsuru S., Miyoshi Y., Ichii S., Nagase H., Ando H., Yanagisawa A., Tsuchiya E., Kato Y., Nakamura Y. Frequent somatic mutations of the APC gene in human pancreatic cancer. Cancer Res. 52:1992;6696-6698.